Genomic Valley Biotech profit shrinks 91% as revenue halves
The biotech's annual revenue fell to ₹26.75 lakhs, while net profit collapsed to ₹3.03 lakhs.
What's new
- FY26 revenue fell 68% to ₹26.75 lakhs from ₹84.84 lakhs in FY25.
- Net profit dropped 91% to ₹3.03 lakhs from ₹35.6 lakhs.
- The board appointed Navjyoti Kumar Jha as internal auditor for FY27.
Why this matters
Profit fell far faster than revenue, pointing to a rigid cost base. For a company with just ₹26.75 lakhs in annual sales, the margin compression leaves almost no buffer.
What we're watching
- Any management commentary on the cause of the 68% revenue drop.
- Whether the new auditor highlights control weaknesses or a going-concern risk.
- Any new contracts or orders to rebuild the top line.
The full read
Genomic Valley Biotech's annual results read like a business in retreat. Revenue fell 68% to ₹26.75 lakhs. Net profit dropped to ₹3.03 lakhs from ₹35.6 lakhs, a decline far steeper than the top line. That points to a cost structure that didn't flex with the sales drop. For a company this small, such a sharp contraction raises immediate questions about its operational runway. The board also named a new internal auditor. That's standard procedure, but it takes on more weight when the underlying business is shrinking this fast. The numbers paint a picture of a company struggling to maintain its scale.
Questions answered
- How severe was the revenue decline?
- Annual revenue fell 68% year-on-year, dropping to ₹26.75 lakhs from ₹84.84 lakhs.
- Why is the profit drop more worrying than the revenue drop?
- Profit fell 91%, far steeper than the 68% revenue decline, indicating that fixed costs did not shrink with sales.
- What was the board's other action during the meeting?
- The board appointed Navjyoti Kumar Jha as internal auditor for the 2026-27 financial year, a standard compliance step.
- What is the scale of the company's operations?
- With FY26 revenue of ₹26.75 lakhs, Genomic Valley is a very small operation. The prior year's ₹84.84 lakhs was also modest.